Some Medicare patients volition beryllium capable to entree to GLP-1 medicine for value nonaccomplishment for the archetypal clip starting July 1, paying a $50 monthly copay done a caller programme designed to marque the drugs much affordable.
Called Medicare GLP-1 Bridge, the aviator programme expands entree to weight-loss drugs made by Eli Lilly and Novo Nordisk, including Zepbound, Foundayo and Wegovy.
"Medicare is not changing the instrumentality close now," said Juliette Cubanski, vice president and manager of Medicare argumentation astatine the wellness attraction probe nonprofit KFF. "What it's doing is taking vantage of a circumstantial conception of the instrumentality that gives the national authorities the quality to basal up a impermanent program."
The programme marks the archetypal clip Medicare volition assistance wage for drugs prescribed solely for obesity, alternatively than limiting sum to radical taking GLP-1s for conditions specified arsenic diabetes oregon cardiovascular disease. Drugmakers have lowered out-of-pocket costs successful caller months, but galore patients inactive wage astir $350 a month.
GLP-1 sum done the span programme volition tally betwixt July 1, 2026, and December 31, 2027. After that 18-month trial, patients could suffer entree to Medicare sum for GLP-1s utilized for value nonaccomplishment unless the Centers for Medicare & Medicaid Services issues an hold oregon Congress changes the law, according to Cubanski. It's imaginable cause manufacturers could besides little their existent direct-to-consumer pricing to lucifer the $50 copay, she said.
"In the abbreviated term, we person this impermanent program, and past nary wide way guardant yet arsenic to what volition hap astatine the extremity of 2027," she said.
Who is eligible?
Medicare beneficiaries with Part D sum enrolled successful an eligible program tin get sum done the Bridge program.
To qualify, a patient's supplier indispensable taxable a anterior authorization request showing that the diligent is being prescribed a GLP-1 for value loss. Prior authorization is simply a process that clears the mode for a pharmacy to capable a prescription.
Providers indispensable besides show that their diligent meets definite objective criteria related to their assemblage wide scale (BMI) and wellness conditions erstwhile they archetypal commencement taking a GLP-1. They indispensable either have:
- BMI of astatine slightest 35
- BMI of astatine slightest 30 positive a past of bosom failure, uncontrolled hypertension oregon chronic kidney disease
- BMI of astatine slightest 27 positive prediabetes, a erstwhile bosom onslaught oregon stroke, oregon symptomatic peripheral artery disease.
Patients are not eligible for sum done the Bridge programme if they already person a GLP-1 medicine nether Medicare Part D for definite conditions, specified arsenic Type 2 diabetes and slumber apnea, according to Cubanski.
"Certainly, for patients who whitethorn deliberation that they're eligible for these drugs oregon are funny successful exploring whether they're eligible, a bully archetypal measurement is to speech to their clinician who tin assistance them," Cubanski said.
What drugs volition Medicare cover?
Eli Lilly's Foundayo, a regular value nonaccomplishment pill, arsenic good arsenic Zepbound KwikPen, a play value nonaccomplishment injection, are covered, on with Novo Nordisk's Wegovy value nonaccomplishment medicine successful injection and pill form.
How overmuch volition I person to pay?
Medicare recipients who conscionable the eligibility requirements volition person to wage a $50 monthly copay to entree the GLP-1 drugs. However, determination are a fewer things to support successful mind. Because the programme is being offered extracurricular Medicare Part D coverage, the copay doesn't number toward a patient's deductible oregon yearly out-of-pocket cap.
"The bully quality is they don't person to conscionable their deductible successful bid to suffice for the $50 copay," Cubanski said. "But connected the different hand, the $50 copay doesn't number towards their $2,100 out-of-pocket cap."
In addition, patients aren't allowed to use coupons oregon discounts to little the terms further.
Edited by Aimee Picchi
In:
Benefits and risks of GLP-1 drugs for kids
Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity
(04:31)

2 days ago
13


English (US) ·